SIGMAR1 and amyotrophic lateral sclerosis: The results of clinical studies are consistent with the development of an ALS-like phenotype with decreased activity of the Sigmar1 gene in vivo and impaired mitochondrial function induced by ALS-causative SIGMA1R mutations in vitro (Figure 3).